Medico Intercontinental Share Price
26.00+0.32 (+1.25%)
-29.60% past 1 Year
Medico Intercontinental was incorporated on August 14, 1984. The company is into the business of trading of Pharmaceutical Products. It is providing a platform to all research based biopharmaceuticals companies
Corporate filings & documents
Announcements
Intimation of Book closure & Annual General Meeting
1 day agoIntimation of Book closure & Annual General Meeting
1 day agoAnnouncement under Regulation 30 (LODR) - Newspaper Publication
2 weeks agoAnnouncement under Regulation 30 (LODR) - Newspaper Publication
2 weeks agoResults for the Quarter ended 30 June 2026
2 weeks agoResults for the Quarter ended 30 June 2026
2 weeks agoPursuant to provisions of Regulation 30 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 14 2026 inter alia considered and approved the matters as mentioned in enclosed file.
2 weeks agoPursuant to provisions of Regulation 30 33 and 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that the Board of Directors of the Company at its meeting held today i.e. August 14 2026 inter alia considered and approved the matters as mentioned in enclosed file.
2 weeks agoMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2026 and any other business items as per agenda circulated.
4 weeks agoMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June 2026 and any other business items as per agenda circulated.
4 weeks agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
1 month agoClosure of Trading Windo
2 months agoClosure of Trading Windo
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Shah & PACs
2 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Shah & PACs
2 months agoSubmission of Disclosure
2 months agoSubmission of Disclosure
2 months agoNewspaper Publication
3 months agoNewspaper Publication
3 months agoIntimation of Re-appointment of an Internal Auditors.
3 months agoIntimation of Re-appointment of an Internal Auditors.
3 months agoResults for the quarter and financial year ended March 31 2026
3 months agoResults for the quarter and financial year ended March 31 2026
3 months agoOutcome of Board meeting dated May 22 2026.
3 months agoMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 inter alia to consider and approve and take on record the Audited Financial Results (Standalone and Consolidated) for quarter and financial year ended March 31 2026 and any other business items as per agenda circulated.
3 months agoAnnual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations 2015 for the financial year ended 31st March 2026.
4 months agoAnnual Secretarial Compliance Report under Regulation 24A of the SEBI (LODR) Regulations 2015 for the financial year ended 31st March 2026.
4 months ago<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Medico Intercontinental Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24100GJ1984PLC111413</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>18.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: PUNEETA SHARMA <br/> Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: JAY SHARADKUMAR SHAH <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 08/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
5 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018
5 months agoClosure of Trading Window
5 months agoClosure of Trading Window
5 months agoNewspaper Publication
6 months agoResults for the quarter and nine months ended December 31 2025.
6 months agoResults for the quarter and nine months ended December 31 2025
6 months agoMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended December 31 2025 and any other business items as per agenda circulated.
7 months agoCompliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
7 months agoClosure of Trading Window
8 months agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Samir Dilipkumar Shah & PACs
8 months agoSubmission of Disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations 2015
8 months agoAnnouncement under Regulation 30 (LODR) - Newspaper Publication
9 months agoResults - Financial results for the quarter and half year ended September 30 2025
9 months agoOutcome of Board meeting held on November 14 2025
9 months agoMedico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Board Meeting Intimation for Compliance of Regulation 29 30 and 33 of the SEBI (LODR) Regulations 2015.
10 months agoCompliances - Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018
11 months agoAnnouncement under Regulation 30 (LODR) - Annual General Meeting updates
11 months agoVOTING RESULTS ALONG WITH SCRUTINIZER REPORT
11 months agoProceedings of the 41st Annual General Meeting of the Company held on September 30 2025.
11 months agoClosure of Trading Window
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2023-06-23
Dividend
0.1
Company details
Registered office
1-5ft Floor, Aditraj Arcade Nr Karma Shreshtha Tower 100 Ft Rd, Satellite Ahmedabad Gujarat PIN: 380015 Tel No: 079 26742739 Fax No: 079 26742740 Email: [email protected] Internet: www.medicointercontinental.com
Registrars
Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg Gala No 9 Shiv Shakti, Industrial Estate,Sitaram Mill Comp. J R Boricha Marg, Lower Parel [E] PIN: Tel No: +91 22 4134 3255/ +91 22 4134 3256 Fax No: NULL Email: [email protected] Internet: www.purvashare.com
Management
Tanvi Shah, Chairman
Samir Shah, Managing Director
Ankur Dave, Non Executive Independent Director
Parshwa Shah, Non Executive Independent Director
Priyank L Sancheti, Non Executive Independent Director
Swati Shah, Non Executive Director
Puneeta Sharma, Company Secretary & Compliance Officer
Details
BSE 539938
NSE NULL
ISIN INE858Q01019